Advent Pharma Ltd. (DSE:ADVENT)

Market Cap	1.37B
Revenue (ttm)	478.96M
Net Income (ttm)	48.69M
Shares Out	93.13M
EPS (ttm)	0.52
PE Ratio	28.12
Forward PE	n/a
Dividend	0.10 (0.68%)
Ex-Dividend Date	Nov 21, 2024

Volume	51,020
Average Volume	412,144
Open	15.40
Previous Close	14.60
Day's Range	14.60 - 15.40
52-Week Range	12.70 - 27.00
Beta	0.44
RSI	43.46
Earnings Date	Oct 28, 2025

About Advent Pharma

Advent Pharma Ltd., a pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh. The company offers poultry, aquaculture, and cattle products. It provides its products in powder, bolus, and liquid dosage forms. Advent Pharma Ltd. was incorporated in 2007 and is based in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 312
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ADVENT

Financial Performance

In 2024, Advent Pharma's revenue was 571.67 million, an increase of 2.44% compared to the previous year's 558.05 million. Earnings were 83.99 million, a decrease of -14.85%.